Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application.
Identifieur interne : 000691 ( PubMed/Corpus ); précédent : 000690; suivant : 000692Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application.
Auteurs : P. Ladyzy Ski ; J M W Jcicki ; J. Krzymie ; J. Blachowicz ; E. J Wicka ; K. Czajkowski ; E. Janczewska ; W. KarnafelSource :
- The International journal of artificial organs [ 0391-3988 ] ; 2001.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Hypoglycemic Agents, Insulin.
- drug therapy : Diabetes Mellitus, Type 1, Pregnancy in Diabetics.
- Adult, Algorithms, Female, Humans, Pregnancy, Software, Telemedicine, Treatment Outcome, User-Computer Interface.
Abstract
A telematic system supporting intensive insulin treatment of pregnant type 1 diabetic out-clinic patients was implemented and technical efficiency of the system was evaluated over long-term ambulatory application. The system consists of a patient teletransmission module (PTM) and a central clinical control unit (CCU). The PTM contains a one-box blood glucose meter and electronic logbook, a modem and a dial-up or cellular phone set. The CCU consists of a PC computer with a modem and DIAPRET - an original program designed to monitor the intensive insulin treatment. The system was installed in the Clinic of Gastroenterology and Metabolic Disease, MA Warsaw and was tested for 166 +/- 24 days on 15 pregnant type 1 diabetic women. Telemonitoring of the patient data was done automatically. No major technical problems with proper operation or handling of the system was noted. Total effectiveness was 69.3 +/- 13.0% and technical effectiveness 91.5 +/- 6.1%. The efficacy of the system was not significantly influenced by patient intelligence level, education level or place of residence (p < 0.05). Significant improvement of metabolic control was noted during application of the system. In conclusion, the telematic system we developed and implemented should have a positive influence on the quality of diabetes treatment during pregnancy.
PubMed: 11314810
Links to Exploration step
pubmed:11314810Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application.</title>
<author><name sortKey="Ladyzy Ski, P" sort="Ladyzy Ski, P" uniqKey="Ladyzy Ski P" first="P" last="Ladyzy Ski">P. Ladyzy Ski</name>
<affiliation><nlm:affiliation>Institute of Biocybernetics and Biomedical Engineering PAS, Warsaw - Poland. Piotr.Ladyzynski@ibib.waw.pl</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="W Jcicki, J M" sort="W Jcicki, J M" uniqKey="W Jcicki J" first="J M" last="W Jcicki">J M W Jcicki</name>
</author>
<author><name sortKey="Krzymie, J" sort="Krzymie, J" uniqKey="Krzymie J" first="J" last="Krzymie">J. Krzymie</name>
</author>
<author><name sortKey="Blachowicz, J" sort="Blachowicz, J" uniqKey="Blachowicz J" first="J" last="Blachowicz">J. Blachowicz</name>
</author>
<author><name sortKey="J Wicka, E" sort="J Wicka, E" uniqKey="J Wicka E" first="E" last="J Wicka">E. J Wicka</name>
</author>
<author><name sortKey="Czajkowski, K" sort="Czajkowski, K" uniqKey="Czajkowski K" first="K" last="Czajkowski">K. Czajkowski</name>
</author>
<author><name sortKey="Janczewska, E" sort="Janczewska, E" uniqKey="Janczewska E" first="E" last="Janczewska">E. Janczewska</name>
</author>
<author><name sortKey="Karnafel, W" sort="Karnafel, W" uniqKey="Karnafel W" first="W" last="Karnafel">W. Karnafel</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2001">2001</date>
<idno type="RBID">pubmed:11314810</idno>
<idno type="pmid">11314810</idno>
<idno type="wicri:Area/PubMed/Corpus">000691</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000691</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application.</title>
<author><name sortKey="Ladyzy Ski, P" sort="Ladyzy Ski, P" uniqKey="Ladyzy Ski P" first="P" last="Ladyzy Ski">P. Ladyzy Ski</name>
<affiliation><nlm:affiliation>Institute of Biocybernetics and Biomedical Engineering PAS, Warsaw - Poland. Piotr.Ladyzynski@ibib.waw.pl</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="W Jcicki, J M" sort="W Jcicki, J M" uniqKey="W Jcicki J" first="J M" last="W Jcicki">J M W Jcicki</name>
</author>
<author><name sortKey="Krzymie, J" sort="Krzymie, J" uniqKey="Krzymie J" first="J" last="Krzymie">J. Krzymie</name>
</author>
<author><name sortKey="Blachowicz, J" sort="Blachowicz, J" uniqKey="Blachowicz J" first="J" last="Blachowicz">J. Blachowicz</name>
</author>
<author><name sortKey="J Wicka, E" sort="J Wicka, E" uniqKey="J Wicka E" first="E" last="J Wicka">E. J Wicka</name>
</author>
<author><name sortKey="Czajkowski, K" sort="Czajkowski, K" uniqKey="Czajkowski K" first="K" last="Czajkowski">K. Czajkowski</name>
</author>
<author><name sortKey="Janczewska, E" sort="Janczewska, E" uniqKey="Janczewska E" first="E" last="Janczewska">E. Janczewska</name>
</author>
<author><name sortKey="Karnafel, W" sort="Karnafel, W" uniqKey="Karnafel W" first="W" last="Karnafel">W. Karnafel</name>
</author>
</analytic>
<series><title level="j">The International journal of artificial organs</title>
<idno type="ISSN">0391-3988</idno>
<imprint><date when="2001" type="published">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Algorithms</term>
<term>Diabetes Mellitus, Type 1 (drug therapy)</term>
<term>Female</term>
<term>Humans</term>
<term>Hypoglycemic Agents (therapeutic use)</term>
<term>Insulin (therapeutic use)</term>
<term>Pregnancy</term>
<term>Pregnancy in Diabetics (drug therapy)</term>
<term>Software</term>
<term>Telemedicine</term>
<term>Treatment Outcome</term>
<term>User-Computer Interface</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Hypoglycemic Agents</term>
<term>Insulin</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Diabetes Mellitus, Type 1</term>
<term>Pregnancy in Diabetics</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Algorithms</term>
<term>Female</term>
<term>Humans</term>
<term>Pregnancy</term>
<term>Software</term>
<term>Telemedicine</term>
<term>Treatment Outcome</term>
<term>User-Computer Interface</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A telematic system supporting intensive insulin treatment of pregnant type 1 diabetic out-clinic patients was implemented and technical efficiency of the system was evaluated over long-term ambulatory application. The system consists of a patient teletransmission module (PTM) and a central clinical control unit (CCU). The PTM contains a one-box blood glucose meter and electronic logbook, a modem and a dial-up or cellular phone set. The CCU consists of a PC computer with a modem and DIAPRET - an original program designed to monitor the intensive insulin treatment. The system was installed in the Clinic of Gastroenterology and Metabolic Disease, MA Warsaw and was tested for 166 +/- 24 days on 15 pregnant type 1 diabetic women. Telemonitoring of the patient data was done automatically. No major technical problems with proper operation or handling of the system was noted. Total effectiveness was 69.3 +/- 13.0% and technical effectiveness 91.5 +/- 6.1%. The efficacy of the system was not significantly influenced by patient intelligence level, education level or place of residence (p < 0.05). Significant improvement of metabolic control was noted during application of the system. In conclusion, the telematic system we developed and implemented should have a positive influence on the quality of diabetes treatment during pregnancy.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">11314810</PMID>
<DateCreated><Year>2001</Year>
<Month>04</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted><Year>2001</Year>
<Month>10</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised><Year>2011</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0391-3988</ISSN>
<JournalIssue CitedMedium="Print"><Volume>24</Volume>
<Issue>3</Issue>
<PubDate><Year>2001</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>The International journal of artificial organs</Title>
<ISOAbbreviation>Int J Artif Organs</ISOAbbreviation>
</Journal>
<ArticleTitle>Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application.</ArticleTitle>
<Pagination><MedlinePgn>157-63</MedlinePgn>
</Pagination>
<Abstract><AbstractText>A telematic system supporting intensive insulin treatment of pregnant type 1 diabetic out-clinic patients was implemented and technical efficiency of the system was evaluated over long-term ambulatory application. The system consists of a patient teletransmission module (PTM) and a central clinical control unit (CCU). The PTM contains a one-box blood glucose meter and electronic logbook, a modem and a dial-up or cellular phone set. The CCU consists of a PC computer with a modem and DIAPRET - an original program designed to monitor the intensive insulin treatment. The system was installed in the Clinic of Gastroenterology and Metabolic Disease, MA Warsaw and was tested for 166 +/- 24 days on 15 pregnant type 1 diabetic women. Telemonitoring of the patient data was done automatically. No major technical problems with proper operation or handling of the system was noted. Total effectiveness was 69.3 +/- 13.0% and technical effectiveness 91.5 +/- 6.1%. The efficacy of the system was not significantly influenced by patient intelligence level, education level or place of residence (p < 0.05). Significant improvement of metabolic control was noted during application of the system. In conclusion, the telematic system we developed and implemented should have a positive influence on the quality of diabetes treatment during pregnancy.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ladyzyński</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Institute of Biocybernetics and Biomedical Engineering PAS, Warsaw - Poland. Piotr.Ladyzynski@ibib.waw.pl</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wójcicki</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Krzymień</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Blachowicz</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jóźwicka</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Czajkowski</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Janczewska</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Karnafel</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Italy</Country>
<MedlineTA>Int J Artif Organs</MedlineTA>
<NlmUniqueID>7802649</NlmUniqueID>
<ISSNLinking>0391-3988</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003922">Diabetes Mellitus, Type 1</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007004">Hypoglycemic Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007328">Insulin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011254">Pregnancy in Diabetics</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012984">Software</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D017216">Telemedicine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D014584">User-Computer Interface</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year>
<Month>4</Month>
<Day>21</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2001</Year>
<Month>10</Month>
<Day>12</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2001</Year>
<Month>4</Month>
<Day>21</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">11314810</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/TelematiV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000691 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000691 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Ticri/CIDE |area= TelematiV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:11314810 |texte= Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:11314810" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a TelematiV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |